Equities research analysts at StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS – Get Free Report) in a research note issued on Friday. The brokerage set a “hold” rating on the stock.
Milestone Scientific Trading Up 1.5 %
Shares of NYSE:MLSS opened at $0.66 on Friday. Milestone Scientific has a twelve month low of $0.52 and a twelve month high of $1.35. The company’s 50 day moving average is $0.69 and its 200 day moving average is $0.66. The company has a market cap of $50.97 million, a PE ratio of -6.60 and a beta of 0.89.
Milestone Scientific (NYSE:MLSS – Get Free Report) last issued its quarterly earnings results on Wednesday, May 15th. The company reported ($0.02) earnings per share for the quarter. The business had revenue of $2.25 million during the quarter. Milestone Scientific had a negative return on equity of 93.64% and a negative net margin of 74.50%.
Milestone Scientific Company Profile
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Further Reading
- Five stocks we like better than Milestone Scientific
- Comparing and Trading High PE Ratio Stocks
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- When to Sell a Stock for Profit or Loss
- AbbVie Stock: A Perfect Dip for Investors to Buy
- 3 REITs to Buy and Hold for the Long Term
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
